John F. McAna, Neil I. Goldfarb, Joseph Couto, Michelle A. Henry, Gary Piefer, and George M. Rapier III:
Improved Cardiac Management with a Disease Management Program Incorporating Comprehensive Lipid Profiling
Population Health Management., ahead of print. Mary Ann Liebert, Inc., publishers
[DOI: 10.1089/pop.2011.0024]
R.J. McDonald, D.F. Kallmes, and H. J. Cloft:
Comparison of Hospitalization Costs and Medicare Payments for Carotid Endarterectomy and Carotid Stenting in Asymptomatic Patients
AJNR Am J Neuroradiol 2011 originally published online on November 24, 2011, American Society of Neuroradiology
[DOI: 10.3174/ajnr.A2791]
Joseph G. Rogers, Robin R. Bostic, Kuo B. Tong, Rob Adamson, Mark Russo and Mark S. Slaughter:
Cost-Effectiveness Analysis of Continuous Flow Left Ventricular Assist Devices as Destination Therapy
Circ Heart Fail. 2011;published online before print November 3 2011, American Heart Association
Janine Biermann, Till Neumann, Christiane E. Angermann, Hans-Dirk Düngen, Raimund Erbel, Wolfgang Herzog, Bernhard Maisch, Thomas Müller-Tasch, Cemil Özcelik und Sabine Pankuweit, et al:
Resource use and costs in systolic heart failure according to disease severity: a pooled analysis from the German Competence Network Heart Failure
Journal of Public Health, Online First, Springer Verlag
[DOI: 10.1007/s10389-011-0452-0]
S. D. Saini, A. M. Fendrick, J. M. Scheiman:
Cost-effectiveness analysis: cardiovascular benefits of proton pump inhibitor co-therapy in patients using aspirin for secondary prevention
Alimentary Pharmacology & Therapeutics, Volume 34, Issue 2, pages 243–251, July 2011, Blackwell Publishing
F. Müller-Riemenschneider, T. Reinhold and S.N. Willich:
Medikamentenfreisetzende Stents der 2. Generation – Neu, aber auch kosteneffektiv?
Second-generation DES – New, but also cost-effective?
Herz, Volume 36, Number 3, 254-261, Urban & Vogel, Muenchen
[DOI: 10.1007/s00059-011-3463-2]
Edward A. Ross MD, Frank B. Bellamy RN, MSN, Scott Hawig CPA, CMA, Amir Kazory MD:
Ultrafiltration for Acute Decompensated Heart Failure: Cost, Reimbursement, and Financial Impact
Clinical Cardiology, Volume 34, Issue 5, pages 273–277, May 2011, John Wiley & Sons
[DOI: 10.1002/clc.20913]
William Galbraith Williams:
Congenital heart disease: interrelation between German diagnoses-related groups system and Aristotle complexity score
European Journal of Cardio-Thoracic Surgery, Editorial comment, Volume 37, Issue 6, June 2010, Pages 1276-1277
[DOI: 10.1016/j.ejcts.2010.02.041]
Gary P. MacDonald, DO, MS:
Cost-Effectiveness of Rosuvastatin for Primary Prevention of Cardiovascular Events According to Framingham Risk Score in Patients With Elevated C-Reactive Protein
JAOA, Vol 110, No 8, August 2010, 427-436, American Osteopathic Association
[JAOA]
Die Seite der DE-Stents wurde für die OPS Version 2011 aktualisiert und für alle Koronarstents angepaßt.
Digg it!
del.icio.us